OR WAIT null SECS
July 02, 2020
Demand for custom drug delivery solutions is increasing and bringing forth an exciting period of valuable, innovative development opportunities.
The COVID-19 pandemic has created a rise in demand for R&D and a shift in focus for some contract organizations.
July 01, 2020
Cambrex has invested in an expansion of its flexible manufacturing facility in Sweden, which will increase the company’s flexible drug substance manufacturing capacity.
May 28, 2020
CordenPharma and Moderna extended a strategic manufacturing services agreement for the supply of lipid excipients to be used in Moderna’s vaccine against SARS-CoV-2.
April 02, 2020
Considering the potential interaction of a drug with the delivery device early on in in development is integral to achieving the best combination.
The new molecules entering the development pipeline are bringing forth exciting challenges in drug delivery.
March 05, 2020
FDA issued a notice to drug compounders regarding the transition of licensure of biologics to the Public Health Service Act.
March 02, 2020
The huge potential of biopharma is presenting an important epoch for outsourcing partners that can support the development and manufacture of biologics in an efficient way.
February 06, 2020
Contract partners must help innovators, especially smaller and virtual companies, consider manufacturability as early as possible in development. This requires focusing on technical and operational performance, as well as cost.
February 02, 2020
Careful design, planning, and record keeping are needed for cleaning and changeover in multiproduct pharmaceutical facilities.